Alexander Siebenhüner

12PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsBehavioural epidemiologyPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 14, 2023
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.

Sylvie Lorenzen, Thorsten Oliver Götze, Peter Thuss-Patience

|Mar 13, 2023
Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study.

Severin A Lautenschlager, Mamadou Pathé Barry, Gerhard Rogler

|Feb 25, 2023
Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association.

Barbara Kneis, Stefan Wirtz, Klaus Weber

|Jan 08, 2023
NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome.

Melanie Langheinrich, Alexander Reinhard Siebenhüner, Justus Baecker

Pageof 2